Multidrug-resistant Acinetobacter baumannii (MDRAB) colonization increases the risk of bacterial spread in the hospital setting. The impact of clinical factors, including antibiotic use, on prolongation of MDRAB colonization has not been investigated. Patients with respiratory tract MDRAB detected using culture were enrolled in this study. Long-term colonizers and short-term colonizers were defined as patients whose colonization periods were ＞30 days or 30 days, respectively. Clinical data were abstracted from medical records. MDRAB was isolated in 34 patients. There were 13 long-term colonizers and 9 short-term colonizers. Twelve patients were lost to follow-up and excluded from the study. There were no significant differences in average leukocyte counts, numbers of antibiotic classes administered, duration of antibiotic use in the 30 days following colonization, or rates of central catheterization or mechanical ventilation between the 2 groups. Long-term colonizers carried Neisseria species (spp.) more frequently in the 30 days following colonization than short-term colonizers (7/13 vs 1/9, p ＝ 0.01); however, this was not the case prior to colonization with MDRAB (5/13 vs 1/9, p ＝ 0.33). The 90-day MDRAB colonization rates for Neisseria-negative patients and Neisseria-positive patients were 10.0z and 83.3z, respectively (P ＜ 0.01). Prolonged MDRAB colonization in the respiratory tract was associated with Neisseria spp. co-colonization.
Multidrug-resistant
Acinetobacter baumannii (MDRAB) is an important pathogen in hospitalacquired infection. MDRAB colonization increases the risk of spread in the hospital setting (1) . Many previous studies have investigated risk factors for acquisition of, or infection with MDRAB (2, 3) . Antibiotic use, dialysis, and prolonged intensive care unit stay have been identified as risk factors for colonization or infection with MDRAB (4) (5) (6) (7) (8) . MDRAB has been associated with co-infecting organisms such as Staphylococcus or Pseudomonas species (spp.) (4) . However, questions about the colonization period of MDRAB and the association of colonization with clinical or microbiological factors have not been answered. We experienced an MDRAB outbreak in our hospital from 2009 to 2011. The objectives of this study were to investigate the duration of MDRAB colonization in the respiratory tract after the acquisition of MDRAB, and the association between duration of MDRAB colonization and clinical or microbiological factors.
All patients with MDRAB on throat or sputum cultures from 25 August 2009 through 17 March 2012 at the Teikyo University Hospital were included. The study site's institutional review board approved the review of the infection control data. Informed consent was waived. The samples were used to inoculate modified CHROMagar Acinetobacter plates (Chromagar, Paris, France), which were then incubated at 379 C and examined after 48 hours for oxidase-negative and bright salmon-red colonies that are indicative of MDRAB. Antimicrobial susceptibilities were analyzed using the current Clinical and Laboratory Standards Institute guidelines. Resistance of the Acinetobacter spp. isolates was tested against meropenem, imipenem, ciprofloxacin, and amikacin, and MDRAB was defined if there was resistance to 3 or all of these antimicrobial agents. Surveillance cultures for MDRAB were performed for all MDRAB-colonized patients every week until MDRAB was no longer detected from throat or sputum cultures. Colonization was defined as repeated isolation of the same bacteria from a patient over time.
The colonization period was defined as the number of days from the first detection of MDRAB through to the first disappearance of the organism. Factors that could potentially influence the duration of MDRAB colonization were abstracted from medical records.
MDRAB was isolated from throat or sputum cultures of 34 patients. The average age of the patients was 71.1 ± 11.3 years (mean ± standard deviation). Twentyfour patients were male. Hematological malignancies were a frequent comorbidity, occurring in 8 patients. Among the 34 MDRAB colonizers, 24 died during the study period due to their primary illnesses. Twelve patients were lost to follow-up.
Patients were followed up for a median of 109 days (range, 2-620 days), during which time a median of 11 serial surveillance cultures (range, 3-76 cultures) were performed for each patient. Clearance of MDRAB colonization occurred in 15 patients who could be followed up during the study period. The median duration of MDRAB colonization was 63 days (range, 3-584 days). The clearance rate of colonization gradually de- MDRAB colonization is thought to persist for a long period after acquisition, although the duration of colonization has not been clearly determined. In our hospital, surveillance for MDRAB carriers was performed every week. In a surveillance study from different body sites of 5 persistent MDRAB carriers, the mean duration of MDRAB colonization was 17.5 months (9) . In a study of patients colonized with Escherichia coli who were treated with fluoroquinolones, the median duration of colonization following hospital discharge was 80 days (10) , which was longer than that of our study. The focus of our study was MDRAB colonization in the respiratory tract, rather than multidrug-resistant Gram-negative bacteria in the rectum. We speculated that the duration of colonization in the respiratory tract might be shorter than that in the intestinal tract because of the burden of bacteria. However, the mechanistic basis of such a potential difference is unclear.
Next, patients were classified as long-term or shortterm colonizers based on duration of MDRAB colonization. Long-term colonizers and short-term colonizers were defined as patients whose colonization period was ＞30 days and 30 days, respectively. There were 13 long-term colonizers and 9 short-term colonizers. Twelve patients were excluded, as they were lost to follow-up. Clinical characteristics of long-term colonizers and short-term colonizers are shown in Table 1 . There were no significant differences between groups in the degree of inflammatory response, nutritional status, number of antibiotic classes administered, duration of antibiotic treatment in the first 30 days after colonization, or rates of central catheterization and mechanical ventilation. Neither colistin nor tigecycline were prescribed for patients in this study. Antibiotic use and insertion of medical devices have been factors associated with colonization or infection with MDRAB (4, 5, 7, 11) . We speculated that the lack of statistical difference in our study might be due to a small sample size.
Numbers of patients with each microbial co-colonization before MDRAB acquisition and 30 days after MDRAB acquisition are shown in Table 2 . Long-term colonizers carried Neisseria spp. more frequently than short-term colonizers; however, this was not the case prior to colonization with MDRAB. The rate of MDRAB colonization between Neisseria-positive patients and Neisseria-negative patients was compared (Fig. 1 ). In the first 90 days, the colonization rate with MDRAB was 10.0z in Neisseria-negative patients and 83.3z in Neisseria-positive patients ( P ＜ 0.01). Neisseria spp. are indigenous microbes in the respiratory tract, although detectability from respiratory samples using culture might be low in this study. However, other respiratory organisms, Streptococcus spp., were not associated with prolongation of MDRAB (Table 2) . From these results, we speculated that co-colonization of Neisseria spp. could be associated with prolongation of MDRAB colonization.
There are no previous reports about the association between prolonged MDRAB and co-colonization with Long Colonization with MDR Acinetobacter baumannii other bacteria, including Neisseria spp. The precise mechanism by which Neisseria co-colonization induced prolongation of MDRAB colonization was not determined. One of the molecules that contributes to adherence of A. baumannii in human epithelial cells is biofilm-associated protein (Bap) (12) , although no report has described the potential environmental factors that can control the differential expression of the bap gene. Another factor that can control the formation of biofilms by A. baumannii is the presence of metal cations, such as iron. The presence of the chelating agent ethylenediaminetetraacetic acid caused a significant reduction in MDRAB attachment and biofilm formation in human respiratory epithelial cells (13) . The lungs are continuously exposed to iron from the atmosphere (14) , and in order to prevent excessive intracellular accumulation, the export of intracellular metals can be mediated by either ferritin or transferrin release. The expression of transporters of iron by N. lactamica was upregulated in the presence of host cells (15) . We speculated that in patients with MDRAB and Neisseria co-colonization of the respiratory tract, regulation of iron transport may be impaired and lead to iron accumulation. Further studies involving the measurement of metals, including iron, in airway secretions in MDRAB carriers are needed.
In conclusion, after the acquisition of MDRAB in the respiratory tract in the hospital setting, duration of MDRAB colonization varied between patients. Cocolonization with Neisseria spp. in the 30 days after MDRAB acquisition was the only risk factor for prolonged MDRAB colonization.
